Evercore ISI analyst Elizabeth Anderson initiated coverage of Privia Health with an Outperform rating and $34 price target. The provider enablement space has “seen its fair share of highflyers and fallen angels,” but Privia stands out as “a slow and steady race winner” and one of the few care platforms serving providers across the spectrum for their entire patient panel, the analyst tells investors. The firm contends Privia is “a reliable performer that ain’t going nowhere, so you can get to know them.”
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on PRVA:
- Privia Health to Participate in Upcoming Investor Conferences
- Privia Health Announces Upsized Pricing of Secondary Offering of $936 Million of Common Stock
- Privia Health Announces Pricing of Secondary Offering of $689 Million of Common Stock
- Privia Health Reports First Quarter 2023 Financial Results
- Privia Health Announces Secondary Offering